Erste Group Bank Issues Negative Estimate for Roche Earnings

Roche Holding AG (OTCMKTS:RHHBY) – Analysts at Erste Group Bank cut their FY2027 EPS estimates for Roche in a research report issued on Thursday, June 25th. Erste Group Bank analyst H. Engel now anticipates that the company will post earnings of $3.34 per share for the year, down from their prior estimate of $3.42. The consensus estimate for Roche’s current full-year earnings is $3.29 per share.

A number of other equities research analysts have also commented on the stock. Argus upgraded shares of Roche from a “hold” rating to a “buy” rating in a report on Monday, April 6th. Morgan Stanley raised shares of Roche from an “underweight” rating to an “equal weight” rating and set a $46.00 target price for the company in a research note on Friday, April 24th. Five investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $51.50.

Roche Trading Down 2.3%

Roche stock opened at $51.35 on Wednesday. The company has a 50 day moving average of $51.21 and a 200-day moving average of $52.65. The company has a current ratio of 1.38, a quick ratio of 1.12 and a debt-to-equity ratio of 0.72. Roche has a twelve month low of $37.51 and a twelve month high of $60.85.

Hedge Funds Weigh In On Roche

Several hedge funds have recently made changes to their positions in RHHBY. McIlrath & Eck LLC bought a new stake in shares of Roche in the first quarter worth $39,000. Opal Capital LLC acquired a new position in Roche during the first quarter worth $4,448,000. PNC Financial Services Group Inc. grew its position in Roche by 5.4% in the first quarter. PNC Financial Services Group Inc. now owns 23,456 shares of the company’s stock valued at $1,166,000 after purchasing an additional 1,201 shares in the last quarter. S&CO Inc. increased its stake in Roche by 163.0% in the 1st quarter. S&CO Inc. now owns 140,551 shares of the company’s stock valued at $6,880,000 after buying an additional 87,107 shares during the last quarter. Finally, Enterprise Financial Services Corp increased its stake in Roche by 6.6% in the 1st quarter. Enterprise Financial Services Corp now owns 5,576 shares of the company’s stock valued at $277,000 after buying an additional 345 shares during the last quarter.

About Roche

Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, founded in 1896 by Fritz Hoffmann‑La Roche. The company operates primarily through two complementary divisions — Pharmaceuticals and Diagnostics — and is known for integrating drug development with diagnostic capabilities to advance personalized healthcare. In the United States and other international markets, shares trade as American Depositary Receipts under the ticker RHHBY (OTCMKTS:RHHBY).

In pharmaceuticals, Roche focuses on developing and commercializing prescription medicines across therapeutic areas including oncology, immunology, infectious diseases and neuroscience, with a notable emphasis on targeted biologics and personalized therapies.